Myositis-associated usual interstitial pneumonia has a better survival than idiopathic pulmonary fibrosis

Rheumatology (United Kingdom)

Volumn 56, Issue 3, 2017, Pages 384-389

  Aggarwal, Rohit ^a   McBurney, Christine ^a   Schneider, Frank ^a   Yousem, Samuel A ^a   Gibson, Kevin F ^a   Lindell, Kathleen ^a   Fuhrman, Carl R ^a   Oddis, Chester V ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Anti synthetase syndrome; Idiopathic pulmonary fibrosis (IPF); Interstitial lung disease (ILD); Myositis; Prognosis; Survival; Usual interstitial pneumonia (UIP)

Indexed keywords

AUTOANTIBODY; EJ AUTOANTIBODY; JO 1 ANTIBODY; KS AUTOANTIBODY; PL 12 AUTOANTIBODY; PL 7 AUTOANTIBODY; RO ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGE; AMERICAN THORACIC SOCIETY CRITERIA; ANTISYNTHETASE SYNDROME; ARTICLE; BLEEDING; CAUCASIAN; CAUSE OF DEATH; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL NERVOUS SYSTEM HEMORRHAGE; CLINICAL OUTCOME; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CUMULATIVE SURVIVAL; DISEASE ASSOCIATION; DISEASE REGISTRY; ETHNICITY; FEMALE; FIBROSING ALVEOLITIS; FORCED VITAL CAPACITY; GENDER; GRAFT FAILURE; HISTOPATHOLOGY; HUMAN; INFECTION; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; KIDNEY FAILURE; LIVER FAILURE; LUNG BIOPSY; LUNG CANCER; LUNG FUNCTION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDIAN SURVIVAL TIME; MIDDLE AGED; MULTIPLE ORGAN FAILURE; MYOSITIS; MYOSITIS ASSOCIATED USUAL INTERSTITIAL PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; PULMONARY EVENT FREE SURVIVAL; PULMONARY HYPERTENSION; RESPIRATORY FAILURE; RESPIRATORY TRACT DISEASE ASSESSMENT; RETROSPECTIVE STUDY; SMOKING; SURVIVAL; SURVIVAL RATE; THORAX RADIOGRAPHY; X-RAY COMPUTED TOMOGRAPHY; AGED; BIOPSY; COMORBIDITY; DIAGNOSTIC IMAGING; IDIOPATHIC PULMONARY FIBROSIS; KAPLAN MEIER METHOD; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; REGISTER;

ADULT; AGED; BIOPSY; CAUSE OF DEATH; COHORT STUDIES; COMORBIDITY; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOSITIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RESPIRATORY INSUFFICIENCY; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85021854791     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kew426     Document Type: Article

References (13)

1. Kalluri M, Oddis CV. Pulmonary manifestations of the idiopathic inflammatory myopathies. Clin Chest Med 2010;31:501-12.
2. Richards TJ, Eggebeen A, Gibson K et al. Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease. Arthritis Rheum 2009;60:2183-92.
3. Aggarwal R, Cassidy E, Fertig N et al. Patients with non- Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients. Ann Rheum Dis 2014;73:227-32.
4. Marie I, Hatron PY, Dominique S et al. Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients. Arthritis Rheum 2011;63:3439-47.
5. Matsushita T, Hasegawa M, Fujimoto M et al. Clinical evaluation of anti-aminoacyl tRNA synthetase antibodies in Japanese patients with dermatomyositis. J Rheumatol 2007;34:1012-8.
6. Schneider F, Aggarwal R, Bi D et al. The pulmonary histopathology of anti-KS transfer RNA synthetase syndrome. Arch Pathol Lab Med 2015;139:122-5.
7. Schneider F, Yousem SA, Bi D et al. Pulmonary pathologic manifestations of anti-glycyl-tRNA synthetase (anti-EJ)- related inflammatory myopathy. J Clin Pathol 2014;67:678-83.
8. Yousem SA, Schneider F, Bi D et al. The pulmonary histopathologic manifestations of the anti-PL7/antithreonyl transfer RNA synthetase syndrome. Human Pathol 2014;45:1199-204.
9. Bohan A, Peter JB, Bowman RL, Pearson CM. Computerassisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine 1977;56:255-86.
10. Aggarwal R, Bandos A, Reed AM et al. Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositis. Arthritis Rheumatol 2014;66:740-9.
11. American Thoracic Society/European Respiratory Society. International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Critical Care Med 2002;165:277-304.
12. Cottin V. Idiopathic interstitial pneumonias with connective tissue diseases features: A review. Respirology 2016;21:245-58.
13. Castelino FV, Goldberg H, Dellaripa PF. The impact of rheumatological evaluation in the management of patients with interstitial lung disease. Rheumatology 2011;50:489-93.